TGen and Circuit Therapeutics lead discoveries that could help patients with neuro-related conditions such as Parkinson’s and drug addictionContinue reading→

UA College of Medicine – Phoenix scientists cross-utilize plant biology, medicine and engineering to create novel platform.Continue reading→

Helios Education Foundation sponsors new program exclusively for high school studentsContinue reading→

Approximately 255 of new funding to be dedicated to neuroscience.Continue reading→

The five-year National Institutes of Health grant will enable Charles Downs, PhD, to study whether the non-pharmacological supplement curcumin can prevent lung injury.Continue reading→

PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reiterated its ongoing efforts to fundamentally transform the company. Below is a synopsis of these ongoing efforts.Continue reading→

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)  announced, on June 15, 2018, that it has entered into a definitive agreement to divest Cord Blood Registry (CBR®) to GI Partners, a private equity investment firm, for $530 million in an all cash sale. The parties expect to close the transaction in the third quarter of 2018.

GI Partners will also simultaneously acquire  California Cryobank (CCB), the world’s premier donor sperm and egg bank in a combined transaction. 

Continue reading→

Allergy sufferers who experience anaphylaxis—an acute, life-threatening allergic reaction requiring urgent treatment—may soon have a new delivery option for receiving a timely dose of epinephrine to avoid a potentially fatal outcome.
Continue reading→